Collegium Pharmaceutical (COLL) Other Accumulated Expenses: 2016-2024
Historic Other Accumulated Expenses for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $4.8 million.
- Collegium Pharmaceutical's Other Accumulated Expenses rose 31.42% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 31.42%. This contributed to the annual value of $4.8 million for FY2024, which is 32.17% up from last year.
- According to the latest figures from FY2024, Collegium Pharmaceutical's Other Accumulated Expenses is $4.8 million, which was up 32.17% from $3.6 million recorded in FY2023.
- Collegium Pharmaceutical's 5-year Other Accumulated Expenses high stood at $4.8 million for FY2024, and its period low was $884,000 during FY2020.
- For the 3-year period, Collegium Pharmaceutical's Other Accumulated Expenses averaged around $3.9 million, with its median value being $3.6 million (2023).
- Per our database at Business Quant, Collegium Pharmaceutical's Other Accumulated Expenses slumped by 72.20% in 2020 and then soared by 221.61% in 2021.
- Collegium Pharmaceutical's Other Accumulated Expenses (Yearly) stood at $884,000 in 2020, then spiked by 221.61% to $2.8 million in 2021, then increased by 21.28% to $3.4 million in 2022, then climbed by 4.41% to $3.6 million in 2023, then skyrocketed by 32.17% to $4.8 million in 2024.